NEWELLINK
Pharmaceuticals, namely agents to treat cancer, autoimmunity, chronic viral infections, and other diseases characterized by abnormal cellular proliferation, and to improve tissue regeneration, wound healing, and transplantation
Abandoned · October 20, 2003 · 76557836 ·